Please login to the form below

Not currently logged in
Email:
Password:

Themis

This page shows the latest Themis news and features for those working in and with pharma, biotech and healthcare.

AZ unveils phase 3 Brilinta data in CAD and type 2 diabetes

AZ unveils phase 3 Brilinta data in CAD and type 2 diabetes

Reduces CV events but falls down on increased bleeding risk. AstraZeneca unveiled the full data set from its phase 3 THEMIS trial at the ESC 2019, which investigated Brilinta in patients ... AZ had hopes to expand the label for Brilinta into this

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics